STAT+: Sana Biotechnology, filing for IPO, aims for astronomical valuation
After years of rumors, Sana Biotechnology is positioning itself to file for an initial public offering that could give it the largest-ever valuation for a pre-clinical company in biotech.
The company is looking to raise just $150 million in an initial public offering, according to a registration statement filed with the Securities and Exchange Commission on Wednesday.
Continue to STAT+ to read the full story…
Read Original Article: STAT+: Sana Biotechnology, filing for IPO, aims for astronomical valuation »
